Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Antibody Test Identifies Scleroderma Patients at High Risk for Pulmonary Hypertension

By LabMedica International staff writers
Posted on 02 May 2022

Scleroderma is caused by the immune system attacking the connective tissue under the skin and around internal organs and blood vessels. More...

This causes scarring and thickening of the tissue in these areas.

There are several different types of scleroderma that can vary in severity. Some types are relatively mild and may eventually improve on their own, while others can lead to severe and life-threatening problems. Detection of certain auto-antibodies flagged patients with scleroderma (also known as systemic sclerosis) who were especially likely to develop pulmonary hypertension over long-term follow-up, have been studied.

Clinical Immunologists at the University of Pittsburgh School of Medicine (Pittsburgh, PA, USA) performed a case-control study where cases were new anti-Th/To antibody (Laboratory Corporation of America, Burlington, NC, USA) positive referrals to Pittsburgh Scleroderma Center from 1980-2015. Controls were the next two consecutive anti-Th/To negative patients seen after a case. Long-term disease manifestations and survival were compared. The scientists identified 204 anti-Th/To positive systemic sclerosis (SSc) patients were and 408 controls. The mean age of the entire cohort was 52 ±12.9 years and 76% were female.

The scientists reported that Anti-Th/To positive patients more often presented without skin thickening and had higher rate of pulmonary hypertension (PH) and interstitial lung disease ILD than controls. They had less frequent muscle and joint involvement. After a median clinical follow-up of 6.1 years, 38% of Th/To patients had developed PH compared to 15% of other SSc patients. The rates of WHO Group 1 pulmonary arterial hypertension (PAH) were 23% in Th/To patients versus 9% in controls. After adjustment for age and gender, anti-Th/To antibody was associated with a 3.3 increased risk of developing PH at 10 years of follow-up from the first SSc center visit. Mortality was also higher in the antibody-positive patients.

The authors concluded that this was the largest cohort of anti-Th/To positive SSc patients with long-term follow-up data. The very high rate (38%) and associated independent risk of anti-Th/To patients developing PH in follow-up, particularly Group 1 PAH was particularly noteworthy. Patients presenting with limited skin involvement should be tested for Th/To antibody. If present, careful monitoring for PH is warranted. The study was published on April 25, 2022 in the journal Arthritis & Rheumatology.

Related Links:
University of Pittsburgh School of Medicine 
Laboratory Corporation of America 


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Portable Electronic Pipette
Mini 96
New
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Silver Member
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: AiPlex VAS for the MosaiQ platform is designed to help reduce time-to-diagnosis for patients with autoimmune vasculitis (Photo courtesy of AliveDx)

Novel Multiplex Assay Supports Diagnosis of Autoimmune Vasculitis

Autoimmune vasculitis and related conditions are difficult to diagnose quickly and accurately, often requiring multiple tests to confirm the presence of specific autoantibodies. Traditional methods can... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.